Hemp Therapies Wiki / Cannabinoids & Plant Chemistry

Terpenes and the Entourage Effect

Terpenes are aromatic compounds hemp and cannabis plants produce alongside cannabinoids. They are chemically distinct from cannabinoids, forming a separate class of plant compound entirely.

What Terpenes Are

Researchers have identified approximately 200–400 different terpenoids across cannabis research, though only a small number have been examined for specific biological activity. Cannabis flower accumulates terpenes alongside cannabinoids, with terpene content commonly described as roughly 8–20% relative to cannabinoid content by weight in the plant material. Terpenes are potent in small quantities — some research notes they can be associated with measurable outcomes even when serum or blood levels of the terpene itself are minimal or undetectable. Sesquiterpenes, the larger terpene molecules, tend to degrade into monoterpenes, the smaller molecules, over time or with exposure to heat, UV, and visible light; terpenoids generally are described as more volatile and more prone to degradation than terpenes.

Common Terpenes and Strain Associations

Myrcene is a terpene commonly associated with Cannabis indica-type chemotypes, while limonene and related terpenes are commonly associated with Cannabis sativa-type chemotypes. Common monoterpenes identified in cannabis include myrcene, limonene, alpha-pinene, beta-pinene, linalool, and terpinolene. Common sesquiterpenes include beta-caryophyllene, humulene, and nerolidol. Beta-caryophyllene stands out among terpenes for binding directly to the CB2 cannabinoid receptor in laboratory research, functioning as a CB2 receptor agonist. Cannabis also contains flavonoid compounds distinct from both cannabinoids and terpenes, including cannaflavins A, B, and C.

The Current State of Entourage-Effect Research

The “entourage effect” is the idea that cannabinoids, terpenes, and flavonoids may interact in combination differently than any single compound would alone. The term was introduced in a 1998 research paper describing how certain inactive metabolites appeared to influence endocannabinoid signaling in specific concentration ranges.

In direct receptor-binding experiments, none of five tested terpenes significantly altered binding at the CB1 receptor; beta-caryophyllene showed a modest displacement effect at the CB2 receptor, to approximately 25% of specific binding, and terpene mixtures did not significantly alter how CBD or THC bound to either receptor. In that same research, no tested terpenes — including myrcene, alpha-pinene, beta-pinene, and limonene — modified cAMP signaling through CB1 or CB2 receptors, either alone or in combination with cannabinoids, and terpenes did not change THC’s potency at either receptor. The researchers concluded their findings add to evidence that a terpene-driven entourage effect cannot be explained by direct action at the CB1 or CB2 receptors, aligning with other similarly negative findings; they suggested any terpene effects, if present, may work through non-cannabinoid-receptor pathways, such as GABA, NMDA, or TRPV1 receptors, or through sensory and aromatic pathways instead.

Mixed results have been reported elsewhere for specific terpene combinations: beta-caryophyllene and terpinolene were associated with CB2-receptor-mediated effects in zebrafish models; myrcene combined with CBD showed no significant difference compared with myrcene alone in one study; linalool has shown sedative potential in isolation, but no effect has been demonstrated so far when linalool is combined with cannabis; and alpha- and beta-pinene showed modest lipid-peroxidation inhibition in laboratory testing but no evidence of neuroprotective effects. Whole-plant cannabis extract has shown greater antitumor activity than purified THC alone in laboratory research, though researchers attributed this to multiple compounds affecting multiple biological targets simultaneously rather than to any specific terpene interaction. As of current published literature, researchers note there are no clinical trials specifically designed to validate the entourage effect in humans, and the potential for terpenes to produce a synergistic or additive interaction with cannabinoids remains unproven.

Terpene Content Across Extraction Methods

CO2 extraction can produce high concentrations of THC and CBD, but at the expense of CBN and terpene content compared with the starting plant material. Ethanol extraction removes undesirable compounds such as chlorophyll and waxes from plant material, but this same broad extractive power also removes monoterpenes and sesquiterpenes along with the unwanted compounds. Distillation can further refine a hemp extract after initial extraction and purification, removing lipids, waxes, and chlorophyll while retaining minor cannabinoids; terpene content is generally lowered or removed during distillation due to terpenes’ volatility under heat. Because sesquiterpenes and terpenoids generally are heat- and light-sensitive, extraction and processing steps involving heat tend to lower total terpene content compared with the original plant material.

Summary

Terpenes are a distinct class of aromatic compound that accompanies cannabinoids in hemp and cannabis, with dozens identified and studied to varying degrees. The entourage-effect hypothesis — that these compounds interact — remains an active area of research with mixed and largely inconclusive findings so far, and no human clinical trials have been designed to test it directly.